Testimonials

The 2009 Rocky Mountain Life Science Investor Conference offered a valuable opportunity for Inviragen to meet with new potential investors and continue discussions with previous contacts. Biotech success is linked to investment and the RMLSIPC brought together interested investors with active biotech companies in the Mountain States region. Inviragen is pleased to have participated in the conference and looks forward to participating again in 2011.”

 

- Dan Stinchcomb, President & CEO, Inviragen, Inc.

 

As a fairly new company, the investor conference was a great event to raise our profile both to the local biotech community and to venture capital investors.  As a result of presenting, we feel like many more people know about Biodesix and what we are trying to accomplish."

 

- Biodesix

 

Given the explosive growth of biotech and medical device companies in the region in the last six years, this conference will provide an excellent opportunity for leading companies to describe their work to interested investors.  Both are likely to be surprised at the opportunities for mutual interest."

- Chris Christoffersen, Partner, Morgenthaler Ventures